Detalles de la búsqueda
1.
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.
Am J Hematol
; 99(4): 763-766, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38317312
2.
Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia.
Cancer Immunol Immunother
; 72(5): 1209-1224, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36376516
3.
Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up.
Br J Haematol
; 194(3): 604-612, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34212373
4.
Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex.
Cell Mol Life Sci
; 77(19): 3885-3903, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820037
5.
Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia.
Br J Haematol
; 189(3): 469-474, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037516
6.
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
Am J Hematol
; 94(11): 1236-1243, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31456269
7.
No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.
Hematol Oncol
; 32(2): 87-93, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23963760
8.
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.
Blood Adv
; 8(10): 2361-2372, 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447114
9.
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib.
Leukemia
; 38(2): 318-325, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129513
10.
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.
Leukemia
; 38(5): 1072-1080, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38548962
11.
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
Am J Hematol
; 93(10): E342-E345, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054949
12.
Current survival measures reliably reflect modern sequential treatment in CML: correlation with prognostic stratifications.
Am J Hematol
; 88(9): 790-7, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23760739
13.
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.
Leukemia
; 36(7): 1879-1886, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35676453
14.
Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy.
BMC Med Res Methodol
; 11: 140, 2011 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21988861
15.
Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice.
Leuk Lymphoma
; 62(1): 194-202, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33021423
16.
[Tyrosine kinase inhibitors in the elderly patients with chronic myeloid leukemia]. / Tyrozinkinázové inhibitory v lécbe starsích pacientu s chronickou myeloidní leukemií.
Vnitr Lek
; 61(9): 760-1, 2015 Sep.
Artículo
en Cs
| MEDLINE | ID: mdl-26790170
17.
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission.
Leukemia
; 34(8): 2113-2124, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32472084
18.
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
Leukemia
; 34(8): 2138-2149, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32601376
19.
BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing.
Am J Hematol
; 89(10): 1016-7, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24984979
20.
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.
Leukemia
; 38(4): 893-897, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472478